VanEck Pharmaceutical ETF (PPH)
NASDAQ: PPH
· Real-Time Price · USD
88.06
0.71 (0.81%)
At close: Jun 24, 2025, 3:59 PM
88.02
-0.05%
After-hours: Jun 24, 2025, 07:29 PM EDT
0.81% (1D)
Bid | 81.85 |
Market Cap | 1.02B |
AUM | 531.82M |
NAV | 87.35 |
EPS (ttm) | 3.81 |
PE Ratio (ttm) | 23.14 |
Shares Out | 11.55M |
Inception Date | Dec 19, 2011 |
Ask | 88.5 |
Volume | 177.7K |
Open | 87.57 |
Previous Close | 87.35 |
Day's Range | 87.30 - 88.39 |
52-Week Range | 77.67 - 99.51 |
Holdings | 25 |
Expense Ratio | 0.36% |
About PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Asset Class Equity
Ticker Symbol PPH
Inception Date Dec 19, 2011
Provider Vaneck
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 72.32% of assets
Name | Symbol | Weight |
---|---|---|
Eli Lilly And Compan... | LLY | 18.48% |
Johnson & Johnson | JNJ | 10.00% |
Novo Nordisk A/s | NVO | 7.69% |
Novartis Ag | NVS | 7.45% |
Merck & Co., Inc. | MRK | 5.97% |
Mckesson Corporation | MCK | 4.69% |
Pfizer Inc. | PFE | 4.58% |
Sanofi | SNY | 4.52% |
Abbvie Inc. | ABBV | 4.47% |
Astrazeneca PLC | AZN | 4.47% |
Dividends Dividend Yield 1.92%
Ex-Dividend | Amount | Payment Date |
---|---|---|
Apr 1, 2025 | $0.5245 | Apr 4, 2025 |
Dec 27, 2024 | $0.4110 | Dec 30, 2024 |
Oct 1, 2024 | $0.4090 | Oct 4, 2024 |
Jul 1, 2024 | $0.3558 | Jul 5, 2024 |
Apr 1, 2024 | $0.5328 | Apr 5, 2024 |